Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maternal immunization and malaria in pregnancy.

Patrick E Duffy1

  • 1Malaria Antigen Discovery Program, Seattle Biomedical Research Institute, 4 Nickerson Street, Suite 200, Seattle, WA 98119, USA. pduffy@sbri.org

Vaccine
|July 10, 2003
PubMed
Summary

Pregnancy malaria, particularly Plasmodium falciparum, causes low birth weight and infant mortality. Vaccines targeting conserved placental parasite antigens are feasible and could enhance infant immunization strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Impact of antigen and carrier substitution on the molecular weight and immunogenicity of the Pfs230D1-CRM197 malaria transmission-blocking vaccine.

Vaccine·2026
Same author

Identification of cross-stage, cross-species malaria CD8<sup>+</sup> T cell antigens.

Nature·2026
Same author

Maternal microchimerism at birth associates with reduced odds of non-malarial fever and respiratory tract infections in Tanzanian children.

PLOS global public health·2026
Same author

Mosquito direct skin feeding bioassay: 15 years of experience and a standardised approach in Mali.

Malaria journal·2026
Same author

Antibody levels to variant and conserved <i>Plasmodium falciparum</i> antigens predict reduction in parasite burden in Malian children.

Frontiers in immunology·2026
Same author

Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysis.

The Lancet. Microbe·2026

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Immunology

Background:

  • Malaria in pregnancy leads to adverse maternal and fetal outcomes, including low birth weight (LBW), contributing to nearly 400,000 infant deaths annually in Africa.
  • Plasmodium falciparum malaria in pregnancy is characterized by infected erythrocyte sequestration in the placenta, potentially impairing antibody transfer and maternal immunization efficacy.
  • Placental malaria parasites exhibit unique adhesive and antigenic properties, distinct from those infecting peripheral blood.

Purpose of the Study:

  • To explore the feasibility of a malaria vaccine for pregnant women.
  • To identify potential vaccine targets based on the distinct features of placental malaria parasites.
  • To assess the impact of pregnancy malaria on maternal immunization and fetal antibody transfer.

Main Methods:

  • Analysis of serologic evidence to identify conserved antigenic targets.
  • Identification of surface proteins expressed by placental parasites as vaccine candidates.
  • Review of existing literature on pregnancy malaria, immune responses, and vaccine strategies.

Main Results:

  • Women develop resistance to pregnancy malaria with successive pregnancies through antibody acquisition against placental parasites.
  • Serologic data suggest conserved antigenic targets for a potential vaccine.
  • Placental malaria can suppress immune responses to other immunogens and reduce materno-fetal antibody transfer.

Conclusions:

  • A vaccine for pregnancy malaria is feasible, targeting conserved antigens on placental parasites.
  • Preventing placental malaria may improve the effectiveness of maternal immunization strategies for neonatal protection against various infections.

Related Experiment Videos